An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumors

We have developed a humanized bi-specific T-cell engager (BiTE) targeting receptor tyrosine kinase-like orphan receptor 1 (ROR1), a cell surface antigen present on a range of malignancies and cancer-initiating cells. Focusing initially on pancreatic cancer, we demonstrated that our ROR1 BiTE results...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Satyen Harish Gohil, Solange Rosa Paredes-Moscosso, Micaela Harrasser, Marzia Vezzalini, Aldo Scarpa, Emma Morris, Andrew M. Davidoff, Claudio Sorio, Amit Chunilal Nathwani, Marco Della Peruta
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Taylor & Francis Group 2017-07-01
coleção:	OncoImmunology
Assuntos:	cancer immunotherapy ror1
Acesso em linha:	http://dx.doi.org/10.1080/2162402X.2017.1326437
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!